Testing effectiveness (Phase 2)Study completedNCT04594005What this trial is testingCDK4/6 Tumor, Abemaciclib, PaclitaxelWho this might be right forTumors Yonsei University 30
Not applicableLooking for participantsNCT06805812What this trial is testingPredicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyWho this might be right forBreast AdenocarcinomaBreast Cancer Stage IVBreast Cancer, Metastatic+38 more Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 3,500
Testing effectiveness (Phase 2)Looking for participantsNCT06365788What this trial is testingBicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast CancerWho this might be right forTriple Negative Breast Neoplasms Universitaire Ziekenhuizen KU Leuven 53
Early research (Phase 1)Looking for participantsNCT05714072What this trial is testingRuxolitinib in Combination With Abemaciclib for the Treatment of MyelofibrosisWho this might be right forMyelofibrosis Due to and Following Polycythemia Vera Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)UnknownNCT04791384What this trial is testingPhase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast CancerWho this might be right forBreast Cancer Criterium, Inc. 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT02846987What this trial is testingStudy of Abemaciclib in Dedifferentiated LiposarcomaWho this might be right forSarcomaDedifferentiated Liposarcoma Memorial Sloan Kettering Cancer Center 33
Testing effectiveness (Phase 2)Study completedNCT02981342What this trial is testingAbemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic Ductal Adenocarcinoma Eli Lilly and Company 106
Testing effectiveness (Phase 2)Looking for participantsNCT05305924What this trial is testingFulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast CancerWho this might be right forER-Positive Breast CancerHER2-negative Breast Cancer The Methodist Hospital Research Institute 28
Testing effectiveness (Phase 2)Looking for participantsNCT06259929What this trial is testingNEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast CancerWho this might be right forBreast Cancer Fondazione Oncotech 51
Testing effectiveness (Phase 2)Study completedNCT03703466What this trial is testingAbemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Eli Lilly and Company 72
Early research (Phase 1)WithdrawnNCT04316169What this trial is testingHydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast CancerWho this might be right forSolid TumorAdvanced Breast Cancer Medical College of Wisconsin
Very early researchWithdrawnNCT04220892What this trial is testingPilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade GliomaWho this might be right forHigh Grade Glioma Jose Carrillo
Early research (Phase 1)Looking for participantsNCT05372640What this trial is testingTesting the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma+3 more National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Looking for participantsNCT05872204What this trial is testingAbemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian CancerWho this might be right forLow Grade Serous Ovarian CarcinomaAdult Type Granulosa Cell Tumor Universitaire Ziekenhuizen KU Leuven 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02747004What this trial is testingAbemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Eli Lilly and Company 234
Early research (Phase 1)Study completedNCT04071262What this trial is testingAbemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 6
Early research (Phase 1)WithdrawnNCT04585724What this trial is testingStereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain MetastasesWho this might be right forAnatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+1 more Emory University
Testing effectiveness (Phase 2)Study completedNCT04408924What this trial is testingAbemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castration-Resistant Prostate Cancer Eli Lilly and Company 44
Early research (Phase 1)Study completedNCT02644460What this trial is testingAbemaciclib in Children With DIPG or Recurrent/Refractory Solid TumorsWho this might be right forDiffuse Intrinsic Pontine GliomaBrain Tumor, RecurrentSolid Tumor, Recurrent+5 more Emory University 53
Very early researchStudy completedNCT04049227What this trial is testingAbemaciclib and Letrozole in Treating Patients With Endometrial CancerWho this might be right forEndometrial Endometrioid Adenocarcinoma Northwestern University 27